NEWHALL CHARLES W III
Insider CIK 1005544 · VTAE Director · FOLD 10% owner · ADNC 10% owner · INHX 10% owner · WDAY 10% owner · INWK 10% owner · SUPN Director, 10% owner · FIO 10% owner · HPTX 10% owner · ECHO 10% owner · PARS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2026-02-24 | 2026-02-25 | 4,475 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2026-02-24 | 2026-02-25 | 4,475 | — | $0 | 124,119 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2026-02-18 | 2026-02-20 | 2,989 | — | $0 | 2,989 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2026-02-18 | 2026-02-20 | 4,977 | — | $0 | 4,977 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 15,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 15,000 | $12.98 | $194.7K | 119,644 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2025-10-09 | 2025-10-10 | 23,800 | $50.73 | $1.21M | 105,844 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2025-10-09 | 2025-10-10 | 1,200 | $51.55 | $61.9K | 104,644 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2025-08-27 | 2025-08-29 | 3,588 | $45.01 | $161.5K | 129,644 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2025-08-25 | 2025-08-27 | 1,000 | $45.00 | $45.0K | 133,232 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2025-08-22 | 2025-08-26 | 1,412 | $45.00 | $63.5K | 134,232 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2025-02-22 | 2025-02-24 | 5,369 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2025-02-22 | 2025-02-24 | 5,369 | — | $0 | 135,644 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2025-02-19 | 2025-02-21 | 4,475 | — | $0 | 4,475 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2025-02-19 | 2025-02-21 | 7,296 | — | $0 | 7,296 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2024-11-11 | 2024-11-12 | 20,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2024-11-11 | 2024-11-12 | 10,700 | $36.24 | $387.8K | 130,275 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2024-11-11 | 2024-11-12 | 20,000 | $9.13 | $182.6K | 140,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2024-02-23 | 2024-02-27 | 3,886 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2024-02-23 | 2024-02-27 | 3,886 | — | $0 | 120,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2024-02-22 | 2024-02-26 | 5,369 | — | $0 | 5,369 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2024-02-22 | 2024-02-26 | 8,252 | — | $0 | 8,252 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2023-11-16 | 2023-11-20 | 7,457 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2023-11-16 | 2023-11-20 | 2,500 | $28.01 | $70.0K | 117,089 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2023-11-16 | 2023-11-20 | 7,457 | $9.24 | $68.9K | 119,589 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2023-02-23 | 2023-02-27 | 3,886 | — | $0 | 3,886 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2023-02-23 | 2023-02-27 | 6,293 | — | $0 | 6,293 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2023-02-22 | 2023-02-24 | 3,882 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2023-02-22 | 2023-02-24 | 3,882 | — | $0 | 112,132 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2022-12-28 | 2022-12-30 | 8,722 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2022-12-28 | 2022-12-30 | 8,722 | $7.90 | $68.9K | 110,453 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2022-02-22 | 2022-02-24 | 6,847 | — | $0 | 6,847 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2022-02-22 | 2022-02-24 | 3,882 | — | $0 | 3,882 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2022-02-19 | 2022-02-23 | 4,222 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2022-02-19 | 2022-02-23 | 4,222 | — | $0 | 101,731 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2021-02-19 | 2021-02-23 | 4,222 | — | $0 | 4,222 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2021-02-19 | 2021-02-23 | 7,365 | — | $0 | 7,365 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2020-02-21 | 2020-02-25 | 9,305 | — | $0 | 9,305 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2020-02-21 | 2020-02-25 | 5,211 | $23.99 | $125.0K | 97,509 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2019-02-22 | 2019-02-26 | 12,427 | — | $0 | 12,427 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2018-02-23 | 2018-02-27 | 8,613 | — | $0 | 8,613 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2017-06-13 | 2017-06-15 | 6,036 | — | $0 | 6,036 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2017-02-24 | 2017-02-27 | 7,905 | — | $0 | 7,905 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2016-03-01 | 2016-03-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-12-03 | 2015-12-07 | 33,127 | — | $0 | 92,298 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-11-11 | 2015-11-13 | 33,159 | — | $0 | 59,171 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | J Other | 2015-07-01 | 2015-07-02 | 289 | — | $0 | 289 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | J Other | 2015-07-01 | 2015-07-10 | 289 | — | $0 | 289 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | J Other | 2015-06-15 | 2015-06-17 | 26,012 | — | $0 | 26,012 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2015-05-28 | 2015-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2015-03-03 | 2015-03-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2014-09-24 | 2014-09-26 | 17,000 | — | $0 | 17,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2014-01-21 | 2014-01-23 | 7,457 | — | $0 | 7,457 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2013-02-05 | 2013-02-07 | 8,722 | — | $0 | 8,722 | SEC↗ |
| WDAY Workday, Inc. | C Conversion deriv | 2012-10-17 | 2012-10-18 | 6,963,636 | — | $0 | 0 | SEC↗ |
| WDAY Workday, Inc. | C Conversion deriv | 2012-10-17 | 2012-10-18 | 6,963,636 | — | $0 | 6,963,636 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-09-04 | 2012-09-06 | 1,066 | — | $0 | 1,066 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-09-04 | 2012-09-06 | 45,000 | — | $0 | 0 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-09-04 | 2012-09-06 | 45,000 | — | $0 | 45,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-09-04 | 2012-09-06 | 4,500,000 | — | $0 | 9,038,379 | SEC↗ |
| FIO FUSION-IO, INC. | S Sale | 2012-08-13 | 2012-08-14 | 2,622 | $25.87 | $67.8K | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 53,787 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 0 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 0 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 2,043 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other deriv | 2012-07-31 | 2012-08-02 | 51,744 | $10.00 | $517.4K | 2,043 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 53,787 | — | $0 | 53,787 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 53,787 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 2,043 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other deriv | 2012-07-31 | 2012-08-02 | 51,744 | $10.00 | $517.4K | 2,043 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 53,787 | — | $0 | 53,787 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 0 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 125,291 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 898,808 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 611,185 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | P Buy | 2012-07-31 | 2012-08-02 | 500,000 | $10.00 | $5.00M | 2,884,221 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 611,185 | — | $0 | 615,119 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 898,808 | — | $0 | 1,513,927 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2012-07-31 | 2012-08-02 | 125,291 | — | $0 | 1,639,218 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other | 2012-07-31 | 2012-08-02 | 51,119 | — | $0 | 1,588,099 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 2,043 | — | $0 | 1,590,142 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 2,043 | — | $0 | 1,592,185 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 434,096 | — | $0 | 2,026,281 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 180,459 | — | $0 | 2,206,740 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 177,481 | — | $0 | 2,384,221 | SEC↗ |
| PARS PHARMOS CORP | A Award deriv | 2012-07-02 | 2012-07-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ADNC AUDIENCE INC | C Conversion deriv | 2012-05-15 | 2012-05-16 | 230,379 | — | $0 | 0 | SEC↗ |
| ADNC AUDIENCE INC | C Conversion deriv | 2012-05-15 | 2012-05-16 | 1,135,843 | — | $0 | 0 | SEC↗ |
| ADNC AUDIENCE INC | C Conversion deriv | 2012-05-15 | 2012-05-16 | 450,952 | — | $0 | 0 | SEC↗ |
| ADNC AUDIENCE INC | C Conversion deriv | 2012-05-15 | 2012-05-16 | 1,111,435 | — | $0 | 0 | SEC↗ |
| ADNC AUDIENCE INC | C Conversion deriv | 2012-05-15 | 2012-05-16 | 1,349,396 | — | $0 | 0 | SEC↗ |
| ADNC AUDIENCE INC | C Conversion | 2012-05-15 | 2012-05-16 | 4,278,005 | — | $0 | 4,278,005 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | C Conversion deriv | 2012-05-04 | 2012-05-08 | 24,965,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | C Conversion | 2012-05-04 | 2012-05-08 | 6,241,250 | — | $0 | 6,241,250 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | P Buy | 2012-05-04 | 2012-05-08 | 4,400,000 | $5.00 | $22.00M | 10,641,250 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-04-27 | 2012-05-01 | 69,998 | — | $0 | 0 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-04-27 | 2012-05-01 | 1,659 | — | $0 | 2,622 | SEC↗ |
| INWK INNERWORKINGS INC | J Other | 2012-03-28 | 2012-03-30 | 500,000 | — | $0 | 4,529,190 | SEC↗ |
| INWK INNERWORKINGS INC | J Other | 2012-03-28 | 2012-03-30 | 5,000 | — | $0 | 15,000 | SEC↗ |
| INWK INNERWORKINGS INC | J Other | 2012-03-26 | 2012-03-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INWK INNERWORKINGS INC | J Other | 2012-03-26 | 2012-03-28 | 1,000,000 | — | $0 | 5,029,190 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-03-14 | 2012-03-16 | 10,000 | — | $0 | 69,998 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-03-14 | 2012-03-16 | 1,000,000 | — | $0 | 13,538,379 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-03-09 | 2012-03-13 | 9,998 | — | $0 | 59,998 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-03-09 | 2012-03-13 | 1,000,000 | — | $0 | 14,538,379 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | P Buy | 2012-03-07 | 2012-03-09 | 214,846 | $5.70 | $1.22M | 1,066,029 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | P Buy | 2012-03-07 | 2012-03-09 | 925,154 | $5.70 | $5.27M | 4,584,311 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-03-05 | 2012-03-07 | 10,000 | — | $0 | 50,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-03-05 | 2012-03-07 | 1,000,000 | — | $0 | 15,538,379 | SEC↗ |
| INWK INNERWORKINGS INC | S Sale | 2012-02-29 | 2012-03-01 | 455,360 | $11.42 | $5.20M | 6,029,190 | SEC↗ |
| ECHO Echo Global Logistics, Inc | J Other | 2012-02-28 | 2012-03-01 | 400,000 | — | $0 | 2,020,219 | SEC↗ |
| ECHO Echo Global Logistics, Inc | J Other | 2012-02-28 | 2012-03-01 | 4,000 | — | $0 | 0 | SEC↗ |
| ECHO Echo Global Logistics, Inc | J Other | 2012-02-28 | 2012-03-01 | 95 | — | $0 | 95 | SEC↗ |
| ECHO Echo Global Logistics, Inc | J Other | 2012-02-28 | 2012-03-01 | 4,000 | — | $0 | 4,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-27 | 2012-02-29 | 1,000,000 | — | $0 | 16,538,379 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-27 | 2012-02-29 | 10,000 | — | $0 | 40,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-24 | 2012-02-27 | 10,000 | — | $0 | 30,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-24 | 2012-02-27 | 1,000,000 | — | $0 | 17,538,379 | SEC↗ |
| INWK INNERWORKINGS INC | S Sale | 2012-02-24 | 2012-02-28 | 334,457 | $11.40 | $3.81M | 6,484,550 | SEC↗ |
| INWK INNERWORKINGS INC | S Sale | 2012-02-23 | 2012-02-24 | 54,849 | $11.75 | $644.5K | 6,819,007 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-23 | 2012-02-27 | 1,000,000 | — | $0 | 18,538,379 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-23 | 2012-02-27 | 10,000 | — | $0 | 20,000 | SEC↗ |
| INWK INNERWORKINGS INC | S Sale | 2012-02-22 | 2012-02-24 | 253,211 | $11.68 | $2.96M | 6,873,856 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-21 | 2012-02-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-21 | 2012-02-23 | 1,000,000 | — | $0 | 19,538,379 | SEC↗ |
| INHX INHIBITEX, INC. | U Tender deriv | 2012-02-13 | 2012-02-15 | 791,015 | — | $0 | 0 | SEC↗ |
| INHX INHIBITEX, INC. | U Tender deriv | 2012-02-13 | 2012-02-15 | 263,671 | — | $0 | 0 | SEC↗ |
| INHX INHIBITEX, INC. | U Tender | 2012-02-13 | 2012-02-15 | 746,596 | $26.00 | $19.41M | 0 | SEC↗ |
| INHX INHIBITEX, INC. | J Other | 2012-02-13 | 2012-02-15 | 746,596 | — | $0 | 746,596 | SEC↗ |
| INHX INHIBITEX, INC. | U Tender | 2012-02-13 | 2012-02-15 | 248,864 | $26.00 | $6.47M | 0 | SEC↗ |
| INHX INHIBITEX, INC. | J Other | 2012-02-13 | 2012-02-15 | 248,864 | — | $0 | 248,864 | SEC↗ |
| INHX INHIBITEX, INC. | U Tender | 2012-02-13 | 2012-02-15 | 6,898,294 | $26.00 | $179.36M | 0 | SEC↗ |
| INHX INHIBITEX, INC. | U Tender | 2012-02-13 | 2012-02-15 | 1,941,407 | $26.00 | $50.48M | 0 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-10 | 2012-02-14 | 1,000,000 | — | $0 | 20,538,379 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-10 | 2012-02-14 | 10,000 | — | $0 | 0 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-10 | 2012-02-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-10 | 2012-02-14 | 240 | — | $0 | 963 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-07 | 2012-02-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-07 | 2012-02-09 | 10,000 | — | $0 | 0 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-07 | 2012-02-09 | 1,000,000 | — | $0 | 21,538,379 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-07 | 2012-02-09 | 240 | — | $0 | 723 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-02 | 2012-02-06 | 483 | — | $0 | 483 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-02 | 2012-02-06 | 20,000 | — | $0 | 0 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-02 | 2012-02-06 | 10,000 | — | $0 | 20,000 | SEC↗ |
| FIO FUSION-IO, INC. | J Other | 2012-02-02 | 2012-02-06 | 1,000,000 | — | $0 | 22,538,379 | SEC↗ |
| PARS PHARMOS CORP | A Award deriv | 2012-01-09 | 2012-01-10 | 25,000 | — | $0 | 25,000 | SEC↗ |